MENU
CASBF
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

CANSINO BIOLOGICS (CASBF) Ownership - Who owns CANSINO BIOLOGICS?

Profile

Industry
N/A
Address
185 South Avenue
Phone
N/A
Employees
2291
Web
https://www.cansinotech.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
1.92B
P/E Ratio
9.30
Total Cash
7.01B
Projected Growth
N/A
Total Debt
2.14B
Revenue
2.87B
Risk (Beta)
1.58
Dividend Yield
0.03
Total Cash/Share
28.31
Total Debt/Equity
N/A
Revenue/Share
0.59 USD as % of share price

Fundamentals

CASBF
Capitalization
1.92B
P/E Ratio
9.30
Risk (Beta)
1.58
Dividend Yield
0.03
Total Cash
7.01B
Total Cash/Share
28.31
Total Debt
2.14B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.59%
Revenue
2.87B
ROE
N/A
Book Value
7.7B
P/B Ratio
0.97
Cash Flow
N/A
Earnings
4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
247M
Current Ratio
2.99
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
1.09B
Float
N/A
Float - Current
N/A
Gross Income Margin
65.66
Revenue To Assets
8.90
Shares Held By Institutions
1.64B
Shares Outstanding - Current
247M
Total Liabilities
3.73B
Total Volume MTD
N/A
Value
1
Gain YTD
18.902
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
185 South Avenue
Phone
N/A
Employees
2291
Web
https://www.cansinotech.com